Strengthening COVID-19 Diagnostic and Laboratory Systems Investments in Africa through Partnerships

The African Society for Laboratory Medicine (ASLM)
  • Duration: 1h 15m

  • Ref. 199810

On 31 March 2022, ASLM’s LabCoP convened an ECHO session on supporting the implementation of diagnostics and laboratory systems investments for COVID-19 in the African region. With funding from The Global Fund and through their Stellar Project, and in collaboration with Africa CDC, ASLM, Association of Public Health Laboratories....

Diagnosing Trichomoniasis

Jackie Sherrard
  • Duration: 30m

  • Ref. 199920

This session explains how to diagnose infection with Trichomonas vaginalis (T. vaginalis). It describes what diagnostic tests are available and the collection and management of suitable samples. It also covers the interpretation of test results.

The Revised ISO 15189:2022 Standard Part 2: Implications at the Country and Facility Levels

Teferi Mekonen and Prof Kilian Songwe
  • Duration: 1h

  • Ref. 199741

The February 2023 LabCoP ECHO session is part 2 of The Revised ISO15189:2022 Standard series. It takes a deep dive into changes needed at country and facilities levels to align to and meet the requirements of the revised standard. The focus is on how to systematically handle the transition for both accredited and non-accredited....

AMR CoP ECHO Session Late Aug 2022: Advancing AMR Surveillance to Public Health Action

Mary Magdalene Osei and Ibrahim Mugerwa
  • Duration: 1h

  • Ref. 199737

In this Antimicrobial (AMR) Community of Practice (CoP) webinar, we discuss the worrying pattern of AMR observed in children under-5 years in one region in Ghana and its implication on AMR National Action Plan (NAP) implementation. We also explore strategies adopted by Uganda to support AMR surveillance and the role of country A....

Integrated Hepatitis Testing as Part of the Response to WHO’s Triple Elimination Strategy

Mr Chukwuemeka Agwuocha
  • Duration: 1h

  • Ref. 199742

LabCoP’s December 2022 ECHO session shares practical insights on integrated testing for HBV and Xpert HCV to align with the World Health Organization’s goal for the triple elimination of HIV, HBV and syphilis. Using a case from Nigeria, we discuss implementation experiences at the point-of-care sites, the existing tuberculosis (....

AMR CoP ECHO Session Oct 2022: Advancing AMR Surveillance Programs

Prof. Jeremiah Seni and Reuben Abednego
  • Duration: 1h

  • Ref. 199736

In this Antimicrobial (AMR) Community of Practice (CoP) webinar, we learn about how Tanzania has managed to implement an AMR surveillance system based on the WHONET software and implementing the WHO Point Prevalence Survey on Antibiotic Use in Hospitals, as part of their National Action Plan on AMR implementation. We also discus....

AMR CoP ECHO Session Dec 2022: Advancing AMR Surveillance in Surgical Interventions

Remy Pacifique Ntirenganya
  • Duration: 1h

  • Ref. 199735

This AMR CoP ECHO session explores surgical site infections and related antibiotic resistance profiles occurring after Bellwether procedures in rural Liberia. In this session, we explore the Liberian experience on antibiotic resistance profiles from surgical site infections that occur after surgery, the main causes of healthcare....

Expanding COVID-19 Testing to Reopen Economies

Dr Jay Varma, Professor David Heyman, Dr Alex Cook, and Carlos Edwardo Gouvea
  • Duration: 1h 15m

  • Ref. 199872

On 2 February, 2021 this COVID-19 ECHO session was convened to discuss expanding COVID-19 testing at schools, borders and at the workplace, in an effort to reopen economies. As many countries over the world are experiencing the second wave of COVID-19, forcing some to go back to stringent lockdown measures, countries are grappli....

New and Emerging Treatments for Heart Failure: HFrEF and HFpEF

Colleen McIlvennan
  • Duration: 1h

  • Ref. 198697

Colleen McIlvennan, PhD, DNP, ANP, FAHA, FHFSA, provides a compelling presentation focusing on the new and emerging treatment for persons with HFrEF (heart failure with reduced ejection fraction) and HFpEF (heart failure with preserved ejection fraction). This presentation includes an overview of the current guidelines for manag....

Aortic Stenosis: Team-Based Care and Shared Decision Making

Patricia Keegan
  • Duration: 30m

  • Ref. 198705

Dr. Patricia Keegan, Nurse Practitioner and Director of the Structural Heart Program at Emory Healthcare in Atlanta, Georgia, reviews the importance of early diagnosis and prompt referral to a valve center to improved health outcomes for those with aortic valve disease. Dr. Keegan describes the decision making that goes into tr....

Severe Malaria

the U.S. Agency for International Development
  • Duration: 1h 15m

  • Ref. 198770

Severe Plasmodium falciparum malaria is a medical emergency. Delay in diagnosis, provision of inappropriate treatment, and delay in treatment may lead to serious complications and even death. The medicine of choice for treatment of severe malaria in order of preference, injectable Artesunate, and injectable Artemether. Injectabl....

Nursing Management of Patient with Hypertension

NSENGIYUMVA Richard and Mr. KARERA Eric
  • Duration: 2h 30m

  • Ref. 198682

The aim of this course is to equip knowledge a nurse regarding assessment and management of hypertension.

Secondary Prevention in Acute Coronary Syndrome: What Nurses Need to Know

Eileen M. Handberg
  • Duration: 1h

  • Ref. 198805

Join Dr. Eileen Handberg as she reviews secondary prevention guidelines for patients with acute coronary syndrome, describes non-statin therapies that may provide additional lipid lowering and risk reduction in high-risk patients hospitalized with acute coronary events, and discusses a team-based approach to managing the transit....

Helping Mothers Survive Pre-Eclampsia & Eclampsia

Laura Fitzgerald and Cherrie Evans
  • Duration: 3h 45m

  • Ref. 198774

This module is designed to address the second leading cause of maternal mortality globally, pre-eclampsia & Eclampsia. Key content in this module includes: correct assessment and classification of hypertensive disorders of pregnancy, administration of loading and maintenance doses of magnesium sulfate and antihypertensive med....

Inflammation and Cardiovascular Disease: Understanding the Relationship

Donna Arnett
  • Duration: 45m

  • Ref. 198804

Donna Arnett, PhD, MSPH, discusses inflammation and chronic inflammatory disease in the context of atherosclerosis. She describes inflammation as a process that links lipids to ASCVD and covers the interconnections between diet, genetics, and physical activity.

Pain Management

DUSHIMIMIMANA SANDRINE, and Mr. KARERA Eric
  • Duration: 4h

  • Ref. 198680

Pain is one of the most common reasons why patients seek medical treatment. Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage. Pain is not just a physical sensation, but it is also influenced by attitudes, beliefs, personality and social factors, and it can affect emotio....

The Paediatric Pandemic: RSV, Adenovirus, Influenza and COVID Update

Cheryl Cohen
  • Duration: 1h 15m

  • Ref. 198896

RSV, Adenovirus, Influenza and COVID-19 in children. A panel discussion on the common respiratory viruses in children and why we've seen a greater surge of infections in children post the COVID-19 lockdown and restrictions.

TB Diagnostic Methods in Ethiopia

Million Molla, Hikma Fekadu, Meazashwork Assefa, Andargachew Kumsa, Eshetu Abdissa, Endale Mengesha, Kalkidan Yae, Tamiru Assefa, Anteneh Kassa, Wondimu Gebrekiristos, Eshetu Kebede, Ekulinet Misganaw, Bekalu Assaminew
  • Duration: 3h

  • Ref. 198874

In this module, we will cover topics on the nationally recommended TB diagnostic methods, their indications, placement and results interpretations. Comparisons of the different bacteriologic methods for TB diagnosis are presented.

Climate Change and the Impact on Child Health

Prof A Coovadia
  • Duration: 45m

  • Ref. 198894

Prof Coovadia gives a great overview of climate change and how Paediatricians and health care facilities should respond to these environmental threats.

Making the Link Between Diabetes and Cardiovascular Disease

Marilyn Tan and Cindy Lamendola
  • Duration: 1h 15m

  • Ref. 198820

With this link between diabetes and cardiovascular disease course, you will learn practical approaches for cardiovascular clinicians to incorporate the treatment of diabetic patients in cardiology practices. Stanford endocrinologist, Dr. Marilyn Tan reviews current clinical practice guidelines and prescribing recommendations for....

Anemia in children

Michael Harrison, and Dr. Jan Du Plessis
  • Duration: 1h 15m

  • Ref. 198935

Learn about Anemia in children

Lipid Management in 2020: The Role of Non-Statin Therapies

Susan Halli-Demeter
  • Duration: 1h

  • Ref. 198825

Susan Halli-Demeter, RN, DNP, CLS reviews the benefits of non-statin, LDL-C-lowering therapies for patients with very high-risk atherosclerotic cardiovascular disease (ASCVD) and severe hypercholesterolemia.

Pediatric Prevention Guidelines

Laura Hayman
  • Duration: 1h

  • Ref. 198810

Dr. Laura Hayman reviews the evidence for starting young when it comes to preventing CVD and highlights strategies and settings for primordial and primary prevention.

SGLT2 Inhibitors and Cardiovascular Outcomes

Darren McGuire, and Cindy Lamendola
  • Duration: 1h 15m

  • Ref. 198818

This SGLT2 inhibitor continuing education course provides timely insights into implementing evidence-based treatment strategies related to atherosclerotic cardiovascular disease, heart failure, and SGLT2 inhibitors. Darren McGuire, MD, MHSc summarizes the glycemic and non-glycemic effects of SGLT2 Inhibitors, and their safety pr....

Point of Care Echocardiography for Shock

Beyra Rossouw
  • Duration: 30m

  • Ref. 198918

There must be very few people in the world who understand cardiac physiology in paediatric shock better than Dr Beyra Rossouw. A qualified paediatric cardiologist and intensivist, in this webinar she takes us through how to do focused point-of-care paediatric echocardiography in shocked patients.